PubMed:32727845 / 1311-1565
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 77-87 | GO:0042571 | denotes | antibodies |
T31 | 115-123 | CHEBI:33893 | denotes | reagents |
T32 | 115-123 | CHEBI:33893 | denotes | reagents |
T33 | 200-208 | GO:0042571 | denotes | antibody |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 200-208 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 115-123 | Chemical | denotes | reagents | http://purl.obolibrary.org/obo/CHEBI_33893 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
28 | 71-76 | Species | denotes | CoV-2 | Tax:2697049 |
29 | 248-253 | Species | denotes | CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 0-254 | Sentence | denotes | Given its high specificity and affinity, we anticipate that these anti-CoV-2 antibodies will be useful as valuable reagents for accessing the antigenicity of vaccine candidates, as well as developing antibody-based therapeutics and diagnostics for CoV-2. |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 0-254 | Sentence | denotes | Given its high specificity and affinity, we anticipate that these anti-CoV-2 antibodies will be useful as valuable reagents for accessing the antigenicity of vaccine candidates, as well as developing antibody-based therapeutics and diagnostics for CoV-2. |